Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Neurologists who Treat Epilepsy (US)(?)

Council Members in this Study Group: 309

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.

Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...

Walter Carlini, MD, PhD
Neurologist
Medford Neurological Clinic, Inc.

Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...

Josef Parvizi, MD, Attending Neurologist, Stanford University Medical CenterJosef Parvizi, MD
Attending Neurologist
Stanford University Medical Center

Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...

John Litton Jr., MD, Chief Executive Officer and President, Litton Family Medicine, PCJohn Litton Jr., MD
Chief Executive Officer and President
Litton Family Medicine, PC

J. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...

Wayel Kaakaji
Chief Executive Officer and Medical Director
Spinal and Neurosurgical Institute

Wayel Kaakaji, MD, is the Chief Executive Officer and Medical Director at the Spinal and Neurosurgical Institute. He has expertise in the management of brain and spine tumors and movement disorder surgery such as deep brain stimulation for Parkinson's disease. Dr. Kaakaji has interest in surgical pain...

Dean Traiger, MD, Physician, Physicians’ Primary Care of Southwest Florida,P.L.Dean Traiger, MD
Physician
Physicians’ Primary Care of Southwest Florida,P.L.

Dean Traiger, MD, is the Owner of Physician's Primary Care of Southwest Florida. Dr. Traiger is board certified in Family Practice and specializes in general primary care across the continuum of pediatrics, adolescent, and adult and geriatric care. He is also focused on diabetes care, hypertension,...

Luc Jasmin, MD, PhD
Attending Neurosurgeon and a Research Scientist
Cedars-Sinai Medical Center

Luc Jasmin, MD, PhD, is an Attending Neurosurgeon and Research Scientist at Cedars Sinai Medical Center in Los Angeles. Dr. Jasmin is involved in a surgical practice and research centered on the treatment of pain and spinal disorders. His clinical work includes cancer spinal surgery as well as treating...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Azilect | 09-02-2008
Author: GLG Expert Contributor

This is a well conceived study and totally convincing

Pain may be caused by anesthesia | 06-30-2008
Analysis of: Why anaesthetics can make the pain worse | www.newscientist.com
Author: GLG Expert Contributor

Pain is a complex of the personal, subjective, and unpleasant experiences  that may or may  not be related to physical injury or tissue damage.  It has been described “timeless, ineluctable, and disconcertingly indefinable.”  The expression may be influenced by psychosocial, ...

Overmedication, and underdiagnosis, are commonplace in the dementia patient | 06-30-2008
Author: Wayel Kaakaji, Chief Executive Officer and Medical Director , Spinal and Neurosurgical Institute

Aricept, Namenda, Risperdal are grossly overused in the treatment of patients with suspected dementia Many patients with dementia have not received proper diagnosis, and do not receive proper treatment Better public and medical education will hopefully reverse this glaring deficit in our medical sy...

Arm Chair Analysis from Monday Morning Quarterbacks provides unrealistic expectations and inappropriate rules | 06-26-2008
Author: GLG Expert Contributor

Medications used for realistic indications and with clinically appropriate symptomatic targets are indicated and provide effectiveness that additional staff cannot offer.  Decision making in health care is too often made by those who do not really provide clinical service but provide arm chair...

Novo Nordisk's Diabetes drug liraglutide is promising | 06-19-2008
Author: GLG Expert Contributor

A direct comparison between liraglutide and exenatide is the best way to show liraglutide's true benefit as a GLP-1 analogue. Novo Nordisk did just that and the results bode well for liraglutide. Once daily liraglutide will soon replace exenatide, given its equivalent efficacy in reducing HbA1c and...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Director
  • President
  • Physician - Division Head

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-05T09:45:16.717